Multiple Manufacturers

METHOTREXATE

Manufacturer:

Multiple Manufacturers

Methotrexate HCPCS:

J9260

HCPCS Code Descriptor:

Injection, methotrexate sodium, 50 mg

Category:

J Code

Methotrexate NDCs:

16729-0277-30, 67457-0466-10, 00703-3675-01, 00703-3671-01, 16729-0277-03, 00703-3678-01, 00703-3678-81, 00143-9519-10, 63323-0123-10, 61703-0350-10, 61703-0408-25, 61703-0350-38, 61703-0124-40, 61703-0408-41, 16729-0277-35, 00143-9367-01, 67457-0480-40, 63323-0122-59, 63323-0122-50, 00143-9830-01

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Multiple

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

67457-0466-10, 00143-9519-10, 61703-0350-10, 61703-0350-38, 61703-0408-41, 67457-0480-40, 63323-0122-59

About Methotrexate:

METHOTREXATE is a medication manufactured by multiple manufacturers and aligned to the J Code: J9260. METHOTREXATE is administered via the injection route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J9260 Added Date:

January 1, 1984

J9260 Effective Date:

January 1, 1997

J9260 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Methotrexate billing and coding information.
Methotrexate patient assistance information can be found through Azurity Solutions at the URL: https://azuritysolutions.com/patients/xatmep/#product
METHOTREXATE prescribing information can be found at the link below:
Information regarding METHOTREXATE’s side effects can be found at MedlinePlus